Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.
Marco BertolottiCarlotta FranchiMarco B L RocchiAndrea MiceliM Vittoria LibbraAlessandro NobiliGiulia LancellottiLucia CarulliChiara Mussinull nullPublished in: Drugs & aging (2017)
In this in-hospital cohort, the use of lipid-lowering agents was mainly driven by patients' clinical history, most notably the presence of clinically overt manifestations of atherosclerosis. Increasing age seems to be associated with lower prescription rates. This might be indicative of cautious behavior towards a potentially toxic treatment regimen.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- cardiovascular disease
- healthcare
- fatty acid
- prognostic factors
- peritoneal dialysis
- risk factors
- emergency department
- type diabetes
- escherichia coli
- patient reported outcomes
- adverse drug
- middle aged
- staphylococcus aureus
- electronic health record
- acute care
- candida albicans
- pseudomonas aeruginosa